High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women

by Carballo-Diéguez A., Balán I., Brown W., Giguere R., Dolezal C., Leu C., Marzinke M., Hendrix C., Piper J., Richardson B., Grossman C., Johnson S., Gomez K., Horn S., Kunjara Na Ayudhya R., Patterson K., Jacobson C., Bekker L., Chariyalertsak S., Chitwarakorn A., Gonzales P., Holtz T., Liu A., Mayer K., Zorrilla C., Lama J., McGowan I., Cranston R.
Published 2017

MTN-017: A rectal phase 2 extended safety and acceptability study of tenofovir reduced-glycerin 1% gel

by Cranston R., Lama J., Richardson B., Carballo-Diéguez A., Na Ayudhya R., Liu K., Patterson K., Leu C., Galaska B., Jacobson C., Parikh U., Marzinke M., Hendrix C., Johnson S., Piper J., Grossman C., Ho K., Lucas J., Pickett J., Bekker L., Chariyalertsak S., Chitwarakorn A., Gonzales P., Holtz T., Liu A., Mayer K., Zorrilla C., Schwartz J., Rooney J., McGowan I.
Published 2017